Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
- 1 July 2008
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 173 (1) , 265-277
- https://doi.org/10.2353/ajpath.2008.071074
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodesBlood, 2007
- An Important Role of Lymphatic Vessels in the Control of UVB-Induced Edema Formation and InflammationJournal of Investigative Dermatology, 2006
- An Unexpected Connection: Lymph Node Lymphangiogenesis and Dendritic Cell MigrationImmunity, 2006
- Novel Function for Vascular Endothelial Growth Factor Receptor-1 on Epidermal KeratinocytesThe American Journal of Pathology, 2005
- Vascular endothelial growth factor promotes sensitivity to ultraviolet B–induced cutaneous photodamageBlood, 2005
- Targeting angiogenesis in cancer: clinical development of bevacizumabNature Clinical Practice Oncology, 2004
- VEGF‐A promotes tissue repair‐associated lymphatic vessel formation via VEGFR‐2 and the α1β1 and α2β1 integrinsThe FASEB Journal, 2004
- Single-Nucleotide Polymorphisms of Vascular Endothelial Growth Factor in Psoriasis of Early OnsetJournal of Investigative Dermatology, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Cytokine Regulation of Proliferation and ICAM-1 Expression of Human Dermal Microvascular Endothelial Cells In VitroJournal of Investigative Dermatology, 1992